Vitro, S.A.B. de C.V. VITOF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 131.88M | 132.27M | 127.81M | 125.46M | 122.26M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 131.88M | 132.27M | 127.81M | 125.46M | 122.26M |
| Cost of Revenue | 62.83M | 63.87M | 64.15M | 65.51M | 50.47M |
| Gross Profit | 69.05M | 68.40M | 63.66M | 59.96M | 71.78M |
| SG&A Expenses | 106.73M | 104.71M | 101.98M | 99.20M | 91.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -4.62M | -7.75M | -7.24M | -4.67M | -3.99M |
| Total Operating Expenses | 164.94M | 160.83M | 158.89M | 160.04M | 138.29M |
| Operating Income | -33.06M | -28.56M | -31.08M | -34.58M | -16.03M |
| Income Before Tax | 60.33M | 108.65M | 122.95M | 120.74M | 49.18M |
| Income Tax Expenses | -7.53M | -1.54M | 14.70M | 15.69M | 10.00M |
| Earnings from Continuing Operations | 67.86 | 110.19 | 108.25 | 105.06 | 39.17 |
| Earnings from Discontinued Operations | 46.68M | 51.96M | 63.98M | 24.56M | 24.56M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 114.54M | 162.15M | 172.23M | 129.62M | 63.73M |
| EBIT | -33.06M | -28.56M | -31.08M | -34.58M | -16.03M |
| EBITDA | -18.35M | -13.47M | -15.58M | -18.85M | -9.25M |
| EPS Basic | 0.24 | 0.39 | 0.42 | 0.34 | 0.20 |
| Normalized Basic EPS | 0.04 | 0.14 | 0.16 | 0.16 | 0.10 |
| EPS Diluted | 0.24 | 0.39 | 0.42 | 0.34 | 0.20 |
| Normalized Diluted EPS | 0.04 | 0.14 | 0.16 | 0.16 | 0.10 |
| Average Basic Shares Outstanding | 1.80B | 1.68B | 1.64B | 1.54B | 1.60B |
| Average Diluted Shares Outstanding | 1.80B | 1.68B | 1.64B | 1.54B | 1.60B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |